Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Insufficient |
In the current state of the dossier and while awaiting the results of the VEG 108844 non-inferiority study comparing VOTRIENT with sunitinib, the Transparency Committee considers that the actual benefit is insufficient to justify reimbursement by National Health Insurance. |
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
rGQeAkXArdknf1Lw
